Press Releases by Industry

2009-07-04 | A US based company has developed a new vaccine production method to combat infectious diseases now seen on a global scale - including the novel H1N1 virus and no-less deadly H5N1 avian flu - in a fraction of the time used by conventional methods.

2009-06-23 | Healthcare providers rate Cardinal Health MedMined as the top infection control product

2009-06-20 | An airport worker whose finger was trapped in the door of a plane has received GBP7,200 compensation.

2009-06-06 | Oral cancer screening system using fluorescence visualization-based technology Is a hit with both practices and patients.

2009-05-23 | Our crime scene cleanup services still include death cleanup and blood cleanup as well as many other services and continue to strive for excellent for our clients with a typical response time of less then 2 hours.

2009-05-21 | We are told to wash or hands, to cover coughs and sneezes, to stay home if we feel sick. Yet to this point only a fraction of purported "flu" cases have been proven to be linked to Influenza, reminds previous Journal of Infectious Diseases lead investigator Lawrence Broxmeyer MD

2009-05-19 | Developed by a Crohn's patient with help from GI specialists, GI Monitor, an iPhone App launched by WellApps, Inc., allows patients with (IBD) Crohn's and Ulcerative Colitis track their symptoms and deliver accurate data to their doctors.

| Video Release

2009-05-08 | Due to a high number of correspondences over these health issues, http://greenefficient.com [Green Efficient], the only US LEED-based building maintenance company, widened their services to help the CDC and health official combat the problem.

2009-05-08 | With all the publicity about so-called "swine" flu, one of the best things anyone can do is be armed with the facts.

| Attachments

2009-05-06 | If taken too late, Tamiflu does little to arrest H1N1 bug and stop spread of virus.

2009-05-05 | Medical researcher/physician Lawrence Broxmeyer MD, lead investigator in a Journal of Infectious Diseases study, has a message for the officials and scientists of WHO and the CDC: There is more to flu-like illness than either "Influenza" or "H1N1".

2009-05-04 | Electrostatic spraying technology provides a superior tool in the fight against Swine Flu. "It's not just what you spray, but how you spray a disinfectant that matters most," says Bruce Whiting of Electrostatic Spraying Systems, Inc. (ESS).

2009-05-04 | ExtraMD, a group of local physicians in Denver, Colorado, is ready to step in and help practices that need extra physicians to see potential "swine flu" patients.

2009-05-02 | Sainsbury's Travel Insurance offers comprehensive cover at competitive premiums, Sainsbury's robust Travel Insurance online and telephone based medical screening process ensures travellers are charged competitive premiums

2009-05-02 | BioScience Laboratories received formal approval from the USDA to acquire, house and work with Swine Influenza VR 333 on April 29, 2009.

2009-05-01 | Research shows that fear can actually lower our immune system response. With the threat of a global pandemic, fear may be our worst enemy. Learn how to conquer fears and maintain wellness.

2009-04-30 | Redbird Armor announces two new NIOSH approved N95 disposable respirators to be used by the workforce and the general public in the event of a medical health emergency such as pandemic influenza.

2009-03-28 | Don't let flea bites make your pets and your family's lives miserable. You can learn how to get rid of fleas from your dogs and cats and out of your home. Find out how with the e-book : "How to Protect Your Pets From Fleas," from http://pestbattle.com/fleas-book/fleasale.php.

2009-03-06 | Miles for Hope, a non-profit organization, dedicated to finding a cure for brain cancer, has partnered with the Dunedin Blue Jays and AirTran Airways to bring you a Guinness World Record Breaking event "Together In Hope" candlelight vigil. All proceeds benefit brain cancer research.

2009-02-25 | The results of a recent survey by BioScience Laboratories to prepare its subject base for upcoming Phase I clinical trials, indicated that 68% of its active subjects pre-qualify for Phase I clinical trials.